A fast-growing pharmaceutical company based in Fort Collins said it's greatly expanding its Colorado presence.

Tolmar Inc., which makes drugs targeting prostate cancer and dermatology drugs, and that operates a 110,000-square-foot research and development facility in Fort Collins, said it plans a big addition to its Windsor facility.

Tolmar said it's adding a 225,000-square-foot manufacturing and administrative site in Windsor.

"We are excited to announce plans to expand our manufacturing capacity to meet the growing demand for the Tolmar portfolio of products," said Tolmar Pharmaceuticals CEO Susan Rodriguez, in a statement.

Read more at the Denver Business Journal: http://bit.ly/2r9Azir